dc.date.accessioned2018-11-30T03:10:45Z
dc.date.available2018-11-30T03:10:45Z
dc.date.created2018-11-30T03:10:45Z
dc.date.issued2018
dc.identifierhttps://hdl.handle.net/20.500.12866/4056
dc.identifierhttps://doi.org/10.1016/j.jaci.2018.06.052
dc.description.abstractBACKGROUND: Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) represents the confluence of bronchial airway hyperreactivity and chronic airflow limitation and has been described as leading to worse lung function and quality of life than found with either singular disease process. OBJECTIVE: We aimed to describe the prevalence and risk factors for ACO among adults across 6 low- and middle-income countries (LMICs). METHODS: We compiled cross-sectional data for 11,923 participants aged 35 to 92 years from 4 population-based studies in 12 settings. We defined COPD as postbronchodilator FEV1/forced vital capacity ratio below the lower limit of normal, asthma as wheeze or medication use in 12 months or self-reported physician diagnosis, and ACO as having both. RESULTS: The prevalence of ACO was 3.8% (0% in rural Puno, Peru, to 7.8% in Matlab, Bangladesh). The odds of having ACO were higher with household exposure to biomass fuel smoke (odds ratio [OR], 1.48; 95% CI, 0.98-2.23), smoking tobacco (OR, 1.28 per 10 pack-years; 95% CI, 1.22-1.34), and having primary or less education (OR, 1.35; 95% CI, 1.07-1.70) as compared to nonobstructed nonasthma individuals. ACO was associated with severe obstruction (FEV1 %, <50; 31.6% of ACO vs 10.9% of COPD alone) and severe spirometric deficits compared with participants with asthma (-1.61 z scores FEV1; 95% CI, -1.48 to -1.75) or COPD alone (-0.94 z scores; 95% CI, -0.78 to -1.10). CONCLUSIONS: ACO may be as prevalent and more severe in LMICs than has been reported in high-income settings. Exposure to biomass fuel smoke may be an overlooked risk factor, and we favor diagnostic criteria for ACO that include environmental exposures common to LMICs.
dc.languageeng
dc.publisherElsevier
dc.relationJournal of Allergy and Clinical Immunology
dc.relation1097-6825
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectACO
dc.subjectadult
dc.subjectaged
dc.subjectallergic asthma
dc.subjectArticle
dc.subjectasthma
dc.subjectAsthma
dc.subjectasthma-COPD overlap
dc.subjectBangladesh
dc.subjectbiomass
dc.subjectbronchodilating agent
dc.subjectchronic obstructive lung disease
dc.subjectchronic obstructive pulmonary disease
dc.subjectCOPD
dc.subjectcross-sectional study
dc.subjectdisease severity
dc.subjectepidemiology
dc.subjectfemale
dc.subjectforced expiratory volume
dc.subjectforced vital capacity
dc.subjecthealth outcomes
dc.subjecthuman
dc.subjectlifestyle
dc.subjectlow income country
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle income country
dc.subjectoverlap
dc.subjectpopulation-based
dc.subjectprevalence
dc.subjectpriority journal
dc.subjectrisk factor
dc.subjectrisk factors
dc.subjectself report
dc.subjectspirometry
dc.subjectwheezing
dc.titleEpidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución